Biolife Solutions
(BLFS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,136 | 19,473 | 27,067 | 24,029 | 59,473 |
| Marketable Securities | 35,780 | 43,260 | 34,583 | 22,546 | N/A |
| Receivables | 30,343 | 33,936 | 32,436 | 31,257 | 24,271 |
| Inventories | 41,329 | 34,904 | 33,747 | 33,335 | 30,200 |
| TOTAL | $132,789 | $138,452 | $135,874 | $118,057 | $118,701 |
| Non-Current Assets | |||||
| PPE Net | 26,100 | 23,638 | 21,737 | 19,117 | 18,259 |
| Investments And Advances | 7,088 | 6,401 | 5,559 | 4,861 | 4,372 |
| Intangibles | 255,370 | 256,829 | 298,754 | 301,265 | 374,027 |
| Other Non-Current Assets | 25,123 | 24,909 | 25,755 | 27,079 | 28,653 |
| TOTAL | $313,681 | $311,777 | $351,805 | $352,322 | $425,311 |
| Total Assets | $446,470 | $450,229 | $487,679 | $470,379 | $544,012 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,250 | 1,814 | 2,067 | 1,363 | 557 |
| Accounts payable and accrued liabilities | 15,525 | 15,367 | 13,140 | 11,537 | 11,711 |
| Accrued Expenses | 10,701 | 9,782 | 7,778 | 7,187 | 6,966 |
| Other current liabilities | 16,776 | 14,601 | 11,038 | 10,325 | 12,860 |
| TOTAL | $47,319 | $44,582 | $36,948 | $33,298 | $35,040 |
| Non-Current Liabilities | |||||
| Long Term Debt | 23,692 | 23,793 | 24,207 | 6,188 | 6,313 |
| Other Non-Current Liabilities | 16,994 | 17,290 | 17,720 | 17,218 | 18,998 |
| TOTAL | $41,044 | $41,459 | $42,482 | $24,768 | $30,452 |
| Total Liabilities | $88,363 | $86,041 | $79,430 | $58,066 | $65,492 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,456 | 43,212 | 42,766 | 42,605 | 42,410 |
| Common Shares | 43 | 43 | 43 | 43 | 42 |
| Retained earnings | -260,629 | -246,915 | -194,597 | -184,640 | -112,086 |
| Other shareholders' equity | -534 | -679 | -1,257 | -900 | -438 |
| TOTAL | $358,107 | $364,188 | $408,249 | $412,313 | $478,520 |
| Total Liabilities And Equity | $446,470 | $450,229 | $487,679 | $470,379 | $544,012 |